Literature DB >> 30762974

Perioperative Pharmacological Sleep-Promotion and Pain Control: A Systematic Review.

Martin F Bjurström1,2,3, Michael R Irwin3.   

Abstract

BACKGROUND: Sleep macrostructure is commonly disturbed after surgery. Postoperative pain control remains challenging. Given the bidirectional interaction between sleep and pain, understanding the role of modulation of sleep during the perioperative period on postoperative pain is needed.
METHODS: This was a systematic review. Controlled trials examining the effects of perioperative sleep-promoting pharmacological agents on postoperative pain and analgesic consumption were identified through a systematic search strategy utilizing multiple electronic databases.
RESULTS: Fourteen studies (9 melatonin, 5 zolpidem) involving 921 patients (melatonin n = 586, zolpidem n = 335) were included. Compared to placebo, melatonin reduced postoperative pain scores by ≥30% and significantly decreased opioid consumption in 3 studies (postoperative day [POD] 1-2), whereas 4 studies reported no significant effect of melatonin on postoperative pain. Compared to placebo, zolpidem reduced postoperative pain scores during POD1-7/POD1-14 in 2 studies, but only 1 trial suggested clinically meaningful improvement (ie, relative reduction of pain score ≥ 30%). Whereas 3 zolpidem trials showed no significant differences regarding postoperative pain ratings, zolpidem treatment was associated with decreased analgesic consumption in 4 out of 5 trials. Several limitations of the included studies were identified; only 1 study out of 14 was deemed to be at low risk of bias, and heterogeneity of the study design and outcome assessment precluded meta-analysis.
CONCLUSION: Perioperative addition of a sleep-promoting pharmacological agent may improve pain control, but underlying evidence is weak and results are inconsistent. Only 5 of the 14 studies objectively evaluated changes in sleep (polysomnography, 2 zolpidem studies; actigraphy, 3 melatonin studies), which complicates conclusions regarding links between perioperative sleep and pain.
© 2019 World Institute of Pain.

Entities:  

Keywords:  analgesia; hypnotics; melatonin; postoperative pain; postoperative period; zolpidem

Year:  2019        PMID: 30762974     DOI: 10.1111/papr.12776

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  5 in total

1.  Zolpidem improves patients' sleep quality after surgical treatment for infective endocarditis: a prospective observational study.

Authors:  Xiangming Hu; Deyi Huang; Caidi Lin; Xiaoming Li; Fen Lu; Wenting Wei; Zhihong Yu; Huosheng Liao; Fang Huang; Xuezhen Huang; Fujun Jia
Journal:  Sleep Breath       Date:  2021-08-27       Impact factor: 2.655

2.  Risk of Postoperative Hyperalgesia in Adult Patients with Preoperative Poor Sleep Quality Undergoing Open-heart Valve Surgery.

Authors:  Zhe Zhang; Hongbai Wang; Yuefu Wang; Qipeng Luo; Su Yuan; Fuxia Yan
Journal:  J Pain Res       Date:  2020-10-13       Impact factor: 3.133

3.  Zolpidem reduces pain intensity postoperatively: a systematic review and meta-analysis of the effect of hypnotic medicines on post-operative pain intensity.

Authors:  Edel T O'Hagan; Markus Hübscher; Christopher B Miller; Christopher J Gordon; Sylvia Gustin; Nancy Briggs; James H McAuley
Journal:  Syst Rev       Date:  2020-09-03

4.  Differential expression of cerebrospinal fluid neuroinflammatory mediators depending on osteoarthritis pain phenotype.

Authors:  Martin Flores Bjurström; Mikael Bodelsson; Agneta Montgomery; Andreas Harsten; Markus Waldén; Shorena Janelidze; Sara Hall; Oskar Hansson; Michael R Irwin; Niklas Mattsson-Carlgren
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

5.  The Effect of Improving Preoperative Sleep Quality on Perioperative Pain by Zolpidem in Patients Undergoing Laparoscopic Colorectal Surgery: A Prospective, Randomized Study.

Authors:  Zhennan Xiao; Bo Long; Zeji Zhao
Journal:  Pain Res Manag       Date:  2022-01-11       Impact factor: 3.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.